1. Comparative effectiveness of incident oral antidiabetic drugs on kidney function. Hung AM, Roumie CL, Greevy RA, Liu X, Grijalva CG, Murff HJ, Ikizler TA, Griffin MR (2012) Kidney Int 81(7): 698-706
    › Primary publication · 22258320 (PubMed) · PMC3306005 (PubMed Central)
  2. Blood pressure control among patients with hypertension and newly diagnosed diabetes. Choma NN, Griffin MR, Kaltenbach LA, Greevy RA, Roumie CL (2012) Diabet Med 29(9): 1126-33
    › Primary publication · 22175281 (PubMed) · PMC4671509 (PubMed Central)
  3. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J, Shay DK, Belongia EA, Griffin MR (2012) Vaccine 30(26): 3937-3943
    › Primary publication · 22484350 (PubMed) · PMC3770527 (PubMed Central)
  4. Adherence to guidelines for respiratory syncytial virus immunoprophylaxis among infants with prematurity or chronic lung disease in three United States counties. Carroll KN, Griffin MR, Edwards KM, Ali A, Zhu Y, Iwane MK, Szilagyi PG, Staat MA, Stevens TP, Hall CB, Williams JV, Hartert TV (2012) Pediatr Infect Dis J 31(11): e229-31
    › Primary publication · 22760537 (PubMed) · PMC3773819 (PubMed Central)
  5. Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis. Fiske CT, Griffin MR, Mitchel E, Sterling TR, Grijalva CG (2012) Pharmacoepidemiol Drug Saf 21(6): 666-9
    › Primary publication · 22532509 (PubMed) · PMC3371104 (PubMed Central)
  6. The effect of incident antidiabetic regimens on lipid profiles in veterans with type 2 diabetes: a retrospective cohort. Roumie CL, Huizinga MM, Liu X, Greevy RA, Grijalva CG, Murff HJ, Hung AM, Griffin MR (2011) Pharmacoepidemiol Drug Saf 20(1): 36-44
    › Primary publication · 21182152 (PubMed)
  7. Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Herrinton LJ, Curtis JR, Chen L, Liu L, Delzell E, Lewis JD, Solomon DH, Griffin MR, Ouellet-Hellstom R, Beukelman T, Grijalva CG, Haynes K, Kuriya B, Lii J, Mitchel E, Patkar N, Rassen J, Winthrop KL, Nourjah P, Saag KG (2011) Pharmacoepidemiol Drug Saf 20(11): 1199-209
    › Primary publication · 21919113 (PubMed) · PMC3312584 (PubMed Central)
  8. Real-world comparison of two molecular methods for detection of respiratory viruses. Ali SA, Gern JE, Hartert TV, Edwards KM, Griffin MR, Miller EK, Gebretsadik T, Pappas T, Lee WM, Williams JV (2011) Virol J : 332
    › Primary publication · 21714915 (PubMed) · PMC3154182 (PubMed Central)
  9. Prevalence and implications of preinjury warfarin use: an analysis of the National Trauma Databank. Dossett LA, Riesel JN, Griffin MR, Cotton BA (2011) Arch Surg 146(5): 565-70
    › Primary publication · 21242422 (PubMed)
  10. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR (2011) JAMA 306(21): 2331-9
    › Primary publication · 22056398 (PubMed) · PMC3428224 (PubMed Central)